FDA Approvals: Synthetic Conjugated Estrogens-A Vaginal Cream and Boostrix
Posted Dec 20 2008 5:43pm
The US Food and Drug Administration (FDA) has approved synthetic conjugated estrogens-A vaginal cream for the treatment of symptoms associated with vulvar and vaginal atrophy due to menopause; and tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine for use in adults aged 19 to 64 years. Synthetic Conjugated Estrogens-A Vaginal Cream (SCE-A Vaginal Cream) Approved to Treat Symptoms of Vulvar and Vaginal Atrophy On November 28, the FDA approved synthetic conjugated estrogens-A 0.625 mg/g vaginal cream (SCE-A Vaginal Cream; Duramed Pharmaceuticals, Inc) for the treatment of moderate to severe vaginal dryness and moderate to severe dyspareunia, which are both symptoms of vulvar and vaginal atrophy due to menopause. SCE-A vaginal cream is administered intravaginally at a recommended dose of 1 g daily for 1 week, followed by a 1-g intravaginal dose twice a week.